RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Operating expenses

ACADIA PHARMACEUTICALS INCACAD

Market cap
$3.9B
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 2024727-9.10%
Dec 31, 2023800+7.96%
Dec 31, 2022741+13.18%
Dec 31, 2021655-10.13%
Dec 31, 2020728+24.37%
Dec 31, 2019586+24.27%
Dec 31, 2018471+12.93%
Dec 31, 2017417+43.83%
Dec 31, 2016290+76.20%
Dec 31, 2015165+76.40%
Dec 31, 201493+136.68%
Dec 31, 201339+52.92%
Dec 31, 201226+3.51%
Dec 31, 201125

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)